BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22311929)

  • 1. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Strbian D; Meretoja A; Ahlhelm FJ; Pitkäniemi J; Lyrer P; Kaste M; Engelter S; Tatlisumak T
    Neurology; 2012 Feb; 78(6):427-32. PubMed ID: 22311929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of the DRAGON score in an elderly Spanish population: prediction of stroke prognosis after IV thrombolysis.
    Giralt-Steinhauer E; Rodríguez-Campello A; Cuadrado-Godia E; Ois Á; Jiménez-Conde J; Soriano-Tárraga C; Roquer J
    Cerebrovasc Dis; 2013; 36(2):110-4. PubMed ID: 24029547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score.
    Strbian D; Engelter S; Michel P; Meretoja A; Sekoranja L; Ahlhelm FJ; Mustanoja S; Kuzmanovic I; Sairanen T; Forss N; Cordier M; Lyrer P; Kaste M; Tatlisumak T
    Ann Neurol; 2012 May; 71(5):634-41. PubMed ID: 22522478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple variables predict miserable outcome after intravenous thrombolysis.
    Seiffge DJ; Karagiannis A; Strbian D; Gensicke H; Peters N; Bonati LH; Kotisaari K; Leppä M; Kejda-Scharler J; Tränka C; Ginsbach P; Tatlisumak T; Lyrer PA; Engelter ST
    Eur J Neurol; 2014 Feb; 21(2):185-91. PubMed ID: 24010545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting stroke outcome using clinical- versus imaging-based scoring system.
    Baek JH; Kim K; Lee YB; Park KH; Park HM; Shin DJ; Sung YH; Shin DH; Bang OY
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):642-8. PubMed ID: 25576347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the ability of the DRAGON score to predict outcome after thrombolysis treatment.
    Ovesen C; Christensen A; Nielsen JK; Christensen H
    J Clin Neurosci; 2013 Nov; 20(11):1635-6. PubMed ID: 24035206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
    Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.
    Van Hooff RJ; Nieboer K; De Smedt A; Moens M; De Deyn PP; De Keyser J; Brouns R
    Clin Neurol Neurosurg; 2014 Oct; 125():189-93. PubMed ID: 25171393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the DRAGON Score in a Chinese Population to Predict Functional Outcome of Intravenous Thrombolysis-Treated Stroke Patients.
    Zhang X; Liao X; Wang C; Liu L; Wang C; Zhao X; Pan Y; Wang Y; Wang Y
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1755-60. PubMed ID: 26028300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice.
    Dirks M; Niessen LW; van Wijngaarden J; Koudstaal PJ; Franke CL; van Oostenbrugge RJ; Dippel DW;
    Int J Stroke; 2012 Jun; 7(4):289-92. PubMed ID: 22168317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Herzig R; Zapletalová J; Horák D; Král M; Skoloudík D; Bártková A; Veverka T; Heřman M; Kaňovský P
    Acta Neurol Scand; 2011 May; 123(5):339-44. PubMed ID: 20597864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke.
    Arenillas JF; Ispierto L; Millán M; Escudero D; Pérez de la Ossa N; Dorado L; Guerrero C; Serena J; Castillo J; Dávalos A
    Neurology; 2008 Jul; 71(3):190-5. PubMed ID: 18625965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.